Emerging research highlighted by Hemp Gazette suggests that more than half of individuals with inflammatory bowel disease (IBD) who use cannabis or CBD products report relief from symptoms such as abdominal pain, stress, anxiety, depression, and nausea. The findings indicate that patients living with chronic conditions like Crohn’s disease and ulcerative colitis are increasingly turning to alternative therapies, with many citing notable improvements in quality of life. The article also notes a reduction in opioid use among some patients, as well as reports of induced remission linked to cannabis or CBD use. However, researchers emphasize the need for more clinical trials to clarify the therapeutic role and long-term impact of cannabis on IBD. To explore these findings in detail, visit the full report at Hemp Gazette.